Thursday, November 30, 2017 9:04:01 PM
Management & VAPOR Wholesale Acquisition
Kevin Frija (CEO) was the former CEO of Vapor Corp that took them from a few million in sales to $25-30M over a few years (market cap height of I believe $100M). He also oversaw the move to the NASDAQ. If you look up a chart of VAPOR adjusted for splits it is crazy…the new management had to dilute due to ultimately poor decisions buying retail stores. Recently VPR Brands acquired Vapor Corp Wholesale assets for a good price (although the convertible note I don’t understand why they did that, more to come)
Share Structure (So far…)
The last 10Q stated they had ~54M shares outstanding but in the “subsequent events” they had to issue another 6M due to the convertible loan from the acquisition. Really hurts because share price is so slow the conversion happened at $0.01!! The convertible loan is almost complete and a move to being cash flow positive is near. This I believe brings share structure to 60M O/S….and will likely grow to let’s say ~65-70M O/S during Q1/Q2 2018 at current cash burn rate prior to cash flow turning around. This isn’t terrible --- but ultimately, I see it as one of the key drivers of the negative reaction in the stock price. This has expanded a small float quite a bit in a short period of time and with the lack of news in the 2nd half of the year, it has been a vicious downward cycle. Not a good thing for earlier investors --- but has given us a great opportunity to buy on the cheap. Volume has picked up now here in the $0.02-$0.04 cent range as the float is being gobbled up and investors find the valuation attractive of $2-2.5M market cap (.5x sales!)
Sales / Brand
The move to focus in the Cannabis space is huge…and HONEYSTICK is a top brand
https://www.marketwatch.com/story/vpr-brands-honeystick-and-gold-nugget-extracts-place-1st-2nd-and-3rd-at-the-high-times-cannabis-cup-2017-04-27
Looking at the recent 10Q last week they show sales growth from $0.6M to $0.9M (+33%). With the CA rec launch in Jan 1 combined with hopefully some new product introductions soon by the company I believe will be a catalyst for continued growth.
The company also received good news in the E-CIG space from the FDA in August.
https://www.marketwatch.com/story/vpr-brands-lp-welcomes-the-fdas-recent-announcement-regarding-electronic-cigarette-regulations-2017-08-01
With the delay until 2022 they will be able to put some efforts into growing their KRAVE and VAPORIN brands. As you see in the 10Q as well the company speaks about continue penetration in the China space for ECIGS.
“We currently market a brand of electronic cigarette e-liquids marketed under the brand “Helium” in the United States and are undertaking efforts to establish distribution of our electronic cigarette e-liquids brand in China. We are currently also identifying electronic cigarette companies that may be infringing our patents and exploring options to license and or enforce our patents”
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=12395008
Not getting into details here but their online websites also work very well and I’m sure have some attractive margins.
Ultimately, the company needs to have sales growth accelerate soon and with a growing cannabis industry, strong brand, online presence, ECIG’s opportunity and a CEO who has LITERALLY DONE IT BEFORE….I think we will see that. Q3 financials last week even showed the start.
While researching, I did see the noise in Q1 when they paid a “advertising company” to promote the product which has caused a stir with earlier investors. I honestly don’t know what went on there but I believe that VPR Brands had good intentions and that is now in the past.
My personal conclusion is that with these small market cap companies you better have strong management and I believe Kevin is just that. He has taken previous company to the NASDAQ, grown sales 10x, etc. He has strong financial interest to add value to the share price. Combine that with a strong brand, growing sales and growing cannabis market that we have a solid risk/reward here.
Speculations here but let's assume $4M in revenues in 2017 – and they are able to grow to $6M in 2018 and $8M in 2019. On $8M in sales, due to their online/wholesale structure and 41% operating margins it is reasonable to assume they could make $1M on the $8M. $1M in 2019 earnings x 25 Forward PE (for a company growing might even be low) is a $25M market cap or $0.33/share. That is my conservative target. If Kevin can build this company into a $15M business you could be talking about $3-4M in OI or closer to $1 share price in 2019/2020.
Risk/Reward at $0.02-0.04 though - I'm in!
Recent VPRB News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 11:00:24 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2024 08:10:02 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:14:37 PM
- VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • InvestorsHub NewsWire • 05/17/2024 12:04:05 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/16/2024 08:06:07 PM
- VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • InvestorsHub NewsWire • 04/19/2024 03:24:43 PM
- Turning Point Brands Canada Named Exclusive Master Distributor for VPR Brands' HoneyStick in Canada • InvestorsHub NewsWire • 01/05/2024 12:13:41 PM
- VPR Brands LP Announces Strong Financial Results for Q3 2023 • InvestorsHub NewsWire • 11/15/2023 12:22:19 PM
- VPRB is Proud to Announce Its Uplisting to the OTCQB Market • InvestorsHub NewsWire • 10/10/2023 11:08:14 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM